Systemic infections and inflammation affect chronic neurodegeneration
The DOI matches its Crossref record; 91 of the 93 references it cites were found in a registry or an index.
Abstract
It is well known that systemic infections cause flare-ups of disease in individuals with asthma and rheumatoid arthritis, and that relapses in multiple sclerosis can often be associated with upper respiratory-tract infections. Here we review evidence to support our hypothesis that in chronic neurodegenerative diseases such as Alzheimer's disease, with an ongoing innate immune response in the brain, systemic infections and inflammation can cause acute exacerbations of symptoms and drive the progression of neurodegeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“chronic systemic inflammation, mostly in the form of infections, has long been associated with behavioral alterations and cognitive dysfunction (50, 51).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [51]
In the citing paper
“gene expression by morphologically identical microglia can differ drastically contingent on context (Perry et al., 2007).”
From Differential roles of microglia and monocytes in the inflamed central nervous system (2014) · cites this paper as Perry et al., 2007
In the citing paper
“Both of these phenomena can be explained by the concept of phenotypic heterogeneity of microglial cell populations100.”
From From inflammation to sickness and depression: when the immune system subjugates the brain (2008) · cites this paper as [100]
In the citing paper
“For example, chronic neurodegenerative diseases are associated with increasing numbers of microglia100.”
From From inflammation to sickness and depression: when the immune system subjugates the brain (2008) · cites this paper as [100]
In the citing paper
“Furthermore, with the deposition of Aβ, the phenotype of microglial cells becomes more neurotoxic118,146–148: they express several inflammatory cytokines, including IL-1β, IL-6, tumour necrosis factor (TNF) and CCL3 (also known as MIP1α)146.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [147]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189 · cited 1×
“It is widely recognized that cells of the macrophage lineage exist in many states of activation, including pro-inflammatory, alternatively activated or even anti-inflammatory, following the ingestion of apoptotic cell”
BackgroundResting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“Although the microglia are phenotypically downregulated, recent imaging studies in vivo show that these cells, even in their so-called resting state, are highly active, with their fine processes continually surveying their local microenvironmen”
BackgroundInflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · cited 1×
“Microglia are exquisitely sensitive to almost any disturbance of brain homeostasi”
BackgroundTracey, K. J. (2002) · Nature · doi:10.1038/nature01321 · Cited by 3,728 · cited 1×
“First, inflammatory events in the thoracic abdominal cavity are signalled to the brain through vagal-nerve sensory afferents, and in turn the vagal efferent outflow might modify these inflammatory events through acetylcholine secretio”
BackgroundImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Biological basis of the behavior of sick animals
Hart, B. L. (1988) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(88)80004-6 · Cited by 2,223
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Cited by
Items 601–700 of 1,000
Systemic Inflammation Causes Microglial Dysfunction With a Vascular AD phenotype
Bathini, P., Dupanloup, I., Zenaro, E., Terrabuio, E., Fischer, A., Ballabani, E., Doucey, M., & Alberi, L. A. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100568 · Cited by 27
TREM2 regulates microglial phagocytosis of synapses in innate immune tolerance
Meng, J., Han, L., Xu, H., Zhang, L., Liu, Z., Zhou, Y., Zhang, X., Luo, H., & Zhang, Y. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111445 · Cited by 26
Pedersen, A. L., Brownrout, J., & Saldanha, C. J. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.10.013 · Cited by 26
“Interestingly, following traumatic brain injury (TBI), although there is no sex difference in the duration of unconsciousness following injury, the predicted outcome and recovery of females are better than for males (Groswasser et al., 1998).”
BackgroundInfluentialPeripheral Blood Inflammatory Cytokines in Idiopathic REM Sleep Behavior Disorder
Kim, R., Jun, J., Kim, H., Jung, K., Shin, Y., Yang, T., Kim, K. T., Kim, T., Byun, J., Sunwoo, J., et al. (2019) · Movement Disorders · doi:10.1002/mds.27841 · Cited by 26
“Systemic inflammation is known to be related to brain inflammation and neurodegeneration.(8) Numerous studies have shown increased peripheral inflammation in PD patients,(9,10) which may contribute to the progress of the disease.”
BackgroundPike, A. F., Kramer, N. I., Blaauboer, B. J., Seinen, W., & Brands, R. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.12.006 · Cited by 26
Callaway, J. K., Wood, C., Jenkins, T. A., Royse, A. G., & Royse, C. F. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.01.032 · Cited by 26
Potential importance of B cells in aging and aging-associated neurodegenerative diseases
Biragyn, A., Aliseychik, M., & Rogaev, E. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-016-0615-8 · Cited by 25
“factors [74] that impair blood-brain-barrier (BBB), activate MG and astrocytes, and induce accumulation of Aβ deposits [1, 61].”
BackgroundInflammation Mediates Body Weight and Ageing Effects on Psychomotor Slowing
Balter, L. J. T., Higgs, S., Aldred, S., Bosch, J. A., & Raymond, J. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-52062-3 · Cited by 25
Parks, R. M., Nunez, Y., Balalian, A. A., Gibson, E. A., Hansen, J., Raaschou‐Nielsen, O., Ketzel, M., Khan, J., Brandt, J. G., Vermeulen, R. C. H., et al. (2022) · Epidemiology · doi:10.1097/ede.0000000000001536 · Cited by 25
Chijiwa, T., Oka, T., Lkhagvasuren, B., Yoshihara, K., & Sudo, N. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.04.050 · Cited by 25
“Considering the present findings with the results of previous studies [46,47], microglial priming may play a pivotal role in the exaggerated sickness response.”
ResultIncreased levels of MIP-1 α in CSF and serum of ALS
Yang, X., Gao, L., Wu, X., Zhang, Y., & Zang, D. (2015) · Acta Neurologica Scandinavica · doi:10.1111/ane.12513 · Cited by 25
“MIP-1a is critical for the accumulation of activated microglial cells (19), while this activated microglial cells mainly result in inflammation responses (2) and play a key role in synthesis and release of several inflammation factors (20).”
BackgroundKurt, B., Ozleyen, A., Antika, G., Yılmaz, Y. B., & Tumer, T. B. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00694 · Cited by 25
Yan, A., Song, L., Zhang, Y., Wang, X., & Liu, Z. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.625166 · Cited by 25
“Researches showed that inflammatory cytokines in the peripheral immune system might amplify neuroinflammation and contribute to the pathogenesis of a neurodegenerative disease (Perry et al., 2007; Cunningham et al., 2009; Ferrari and Tarelli, 2011).”
BackgroundMicroglial activation and age-related dopaminergic neurodegeneration in MPTP-treated SAMP8 mice
Liu, J., Wang, M., Gu, P., Ma, Q., Wang, Y.-Y., Geng, Y., Yuan, Z.-Y., Cui, D., Zhang, Z., Ma, L., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.043 · Cited by 25
“…in the brains of mice at different ages, suggesting that the increase neuronal degeneration is not caused by the higher concentration of MPP+ (Ricaurte et al., 1987), but rather the higher levels of oxidative stress, decreased amounts of endogenic anti-oxidizing material, and the prolonged…”
Computational modeling of cytokine signaling in microglia
Anderson, W. D., Makadia, H. K., Greenhalgh, A. D., Schwaber, J. S., David, S., & Vadigepalli, R. (2015) · Molecular BioSystems · doi:10.1039/c5mb00488h · Cited by 25
N-3 polyunsaturated fatty acid and neuroinflammation in aging and Alzheimer's disease
Layé, S., Madore, C., St‐Amour, I., Delpech, J.-C., Joffre, C., Nadjar, A., & Calon, F. (2015) · Nutrition and Aging · doi:10.3233/nua-150049 · Cited by 25
“One of the most important new knowledge is that microglia become more susceptible to inflammatory stimuli when they are primed by pathological insults contributing to the progression of neurodegenerative diseases such as Alzheimer’s Disease (AD) [73, 74].”
Huang, H.-T., Chen, P. S., Kuo, Y., & Tzeng, S. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01837-x · Cited by 24
“Systemic infection that can cause neurodegeneration and affective behaviors at the later-life time points have been documented [21, 22].”
BackgroundAn astrocyte cell line that differentially propagates murine prions
Tahir, W., Abdulrahman, B., Abdelaziz, D. H., Thapa, S., Walia, R., & Schätzl, H. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.012596 · Cited by 24
“It has been reported that chronic neuroinflammation is generally associated with reactive microgliosis and astrogliosis, considered pathological hallmarks of neurodegenerative diseases including Alzheimer’s, Parkinson’s, amyotrophic lateral sclerosis, and prion diseases (61).”
BackgroundHepatitis C Virus-Related Central and Peripheral Nervous System Disorders
Moretti, R., Giuffrè, M., Merli, N., Caruso, P., Bella, S. D., Tiribelli, C., & Crocè, L. S. (2021) · Brain Sciences · doi:10.3390/brainsci11121569 · Cited by 24
Association of Influenza Vaccination and Dementia Risk: A Meta-Analysis of Cohort Studies
Sun, H., Liu, M., & Liu, J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221036 · Cited by 24
Immunomodulatory Effects of Clozapine: More Than Just a Side Effect in Schizophrenia
Amerio, A., Magnani, L., Arduino, G., Fesce, F., de Filippis, R., Parise, A., Costanza, A., Nguyen, K. D., Saverino, D., Berardis, D. D., et al. (2023) · Current Neuropharmacology · doi:10.2174/1570159x22666231128101725 · Cited by 24
“Crosstalk between microglia and neuro-glial environment is now recognized as essential for maintaining brain homeostasis [15, 16].”
BackgroundHeide, E. C., Bîndilă, L., Post, J. M., Malzahn, D., Lutz, B., Seele, J., Nau, R., & Ribes, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02671 · Cited by 24
“Primed/reactive microglial cells amplify and prolong inflammation upon infection, and exacerbate neurocognitive disability in elderly patients (18).”
BackgroundTorvell, M., Hampton, D. W., Connick, P., MacLullich, A. M. J., Cunningham, C. M., & Chandran, S. (2019) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.09.001 · Cited by 24
Self-citationInvolvement of the Choroid Plexus in the Pathogenesis of Niemann-Pick Disease Type C
Hoecke, L. V., Cauwenberghe, C. V., Dominko, K., Imschoot, G. V., Wonterghem, E. V., Castelein, J., Xie, J., Claeys, W., Vandendriessche, C., Kremer, A., et al. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.757482 · Cited by 24
“Central nervous system inflammation is a common feature of neurodegenerative diseases, including lysosomal storage disorders (Perry et al., 2007).”
BackgroundPreventing dementia: role of vascular risk factors and cerebral emboli
Purandare, N. B. (2009) · British Medical Bulletin · doi:10.1093/bmb/ldp020 · Cited by 25
Dankel, S. J., Loenneke, J. P., & Loprinzi, P. D. (2016) · International Journal of Behavioral Medicine · doi:10.1007/s12529-016-9541-3 · Cited by 24
Muth, C., Schröck, K., Madore, C., Hartmann, K., Fanek, Z., Butovsky, O., Glatzel, M., & Krasemann, S. (2017) · Brain Pathology · doi:10.1111/bpa.12441 · Cited by 23
Skrede, K., Wyller, T. B., Watne, L. O., Seljeflot, I., & Juliebø, V. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1129-5 · Cited by 23
“A number of mechanisms have been proposed, mainly emphasizing neurotransmission, inflammation, and chronic stress [2-4].”
Shang, T., Ma, B., Shen, Y., Wei, C., Wang, Z., Zhai, W., Li, M., Wang, Y., & Sun, L. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.907486 · Cited by 23
“Central inflammation interferes with neurogenesis, synaptic plasticity, and neurotransmission, which in turn leads to brain atrophy and cognitive impairment (27).”
BackgroundContreras, J. A., Aslanyan, V., Albrecht, D., Mack, W. J., Initiative, A. D. N., & Pa, J. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12346 · Cited by 23
Cerebrolysin attenuates cerebral and hepatic injury due to lipopolysaccharide in rats
Abdel‐Salam, O. M. E., Omara, E. A., Mohammed, N. A., Youness, E. R., Khadrawy, Y. A., & Sleem, A. A. (2013) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2013.v7.6.261 · Cited by 23
Bowyer, A., & Royse, C. F. (2016) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000399 · Cited by 23
Shahraz, A., Wißfeld, J., Ginolhac, A., Mathews, M., Sinkkonen, L., & Neumann, H. (2020) · Glia · doi:10.1002/glia.23890 · Cited by 23
Transcriptomics of cortical gray matter thickness decline during normal aging
Kochunov, P., Charlesworth, J., Winkler, A. M., Hong, L. E., Nichols, T. E., Curran, J. E., Sprooten, E., Jahanshad, N., Thompson, P. M., Johnson, M. P., et al. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.05.066 · Cited by 23
“However, chronic activation of immune pathways by the endogenous amyloid-beta peptide is thought to be the chief contributing factor to neurodegeneration in AD (Perry et al., 2007; Rivest, 2009).”
BackgroundEbert, S., Goos, M., Rollwagen, L., Baake, D., Zech, W., Esselmann, H., Wiltfang, J., Mollenhauer, B., Schliebs, R., Gerber, J., et al. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22270 · Cited by 17
“VC 2009 Wiley-Liss, Inc. Key words: amyotrophic lateral sclerosis; Alzheimer’s disease; Parkinson’s disease; systemic infection; Streptococcus pneumoniae Neurological symptoms of patients suffering from neurodegenerative diseases often worsen during infections (Perry et al., 2003, 2007).”
BackgroundRodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches
Farrell, C., Mumford, P., & Wiseman, F. K. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.909669 · Cited by 22
“Peripheral or systemic infection can drive neuroinflammation and worsen cognitive decline and pathology in AD (Perry et al., 2007; Cunningham et al., 2009).”
BackgroundJi, C., Yan, Y., Yuan, F., Cao, J., Li, S., Eickhoff, S. B., & Zhang, J. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.11.020 · Cited by 22
“Corroborating with the previous literature (Raghavendraet al., 2004; Perry et al., 2007), neurodegeneration and glial activation may implicate the cellular pathology underpinning the brain deficits in systemic infections and inflammation.”
BackgroundProspective investigation of herpesvirus infection and risk of glioma
Coghill, A. E., Kim, Y., Hodge, J. M., Bender, N., Smith‐Warner, S. A., Teras, L. R., Grimsrud, T. K., Waterboer, T., & Egan, K. M. (2022) · International Journal of Cancer · doi:10.1002/ijc.33987 · Cited by 22
Landolfo, E., Cutuli, D., Decandia, D., Balsamo, F., Petrosini, L., & Gelfo, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065404 · Cited by 22
Puppel, K., Kuczyńska, B., Nałęcz‐Tarwacka, T., Gołębiewski, M., Sakowski, T., Kapusta, A., Budziński, A., & Balcerak, M. (2015) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.7341 · Cited by 22
Aging and Neuroinflammatory Disorders: New Biomarkers and Therapeutic Targets
Gambino, C. M., Sasso, B. L., Bivona, G., Agnello, L., & Ciaccio, M. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191112093034 · Cited by 22
Serum TNF-α and neurodegeneration in isolated REM sleep behavior disorder
Kim, R., Lee, J., Kim, H., Kim, Y. K., Nam, H., & Jeon, B. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.09.041 · Cited by 22
P2X7 Receptor as a Potential Target for Major Depressive Disorder
Huang, Z., & Tan, S. (2021) · Current Drug Targets · doi:10.2174/1389450122666210120141908 · Cited by 23
LPS Primes Brain Responsiveness to High Mobility Group Box-1 Protein
Peek, V., Harden, L. M., Damm, J., Aslani, F., Leisengang, S., Roth, J., Gerstberger, R., Meurer, M., von Köckritz‐Blickwede, M., Schulz, S., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14060558 · Cited by 22
“Systemic inflammation, induced by lipopolysaccharide (LPS), a compound of Gramnegative bacterial cell walls, can exacerbate ongoing brain pathologies including neurodegeneration [13] or stroke [14,15].”
BackgroundRubin, K., & Glazer, S. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.09.017 · Cited by 22
“Others have proposed that systemic inflammatory disease may drive neurodegeneration in AD (Perry et al., 2007).”
Immunomodulatory Properties of Carvone Inhalation and Its Effects on Contextual Fear Memory in Mice
Lasarte-Cía, A., Lozano, T., Pérez-González, M., Gorraiz, M., Iribarren, K., Hervás‐Stubbs, S., Sarobe, P., Rabal, O., Cuadrado‐Tejedor, M., García‐Osta, A., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00068 · Cited by 22
“Infections, injuries, or severe or chronic stressful conditions can activate the immune system promoting the production of high levels of pro-inflammatory cytokines and other mediators that can influence behavior (5, 40, 41) and produce direct detrimental effects on memory, neural plasticity, and neurogenesis (42, 43)…”
BackgroundEkladious, S. T., & Sayed, N. S. E. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000407 · Cited by 22
van Rees, G. F., Lago, S. G., Cox, D., Tomasik, J., Rustogi, N., Weigelt, K., Özcan, S., Cooper, J. D., Drexhage, H. A., Leweke, F. M., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.10.003 · Cited by 22
“We build on previous evidence that the peripheral immune system can signal through the blood–brain barrier and alter the phenotype of brain-resident microglia (Dantzer et al., 2008; Perry et al., 2010, 2007).”
Zhao, M., Ma, G., Yan, X., Li, X., Wang, E., Xu, X.-X., Zhao, J.-B., Ma, X., & Zeng, J. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02428-5 · Cited by 21
Pre-surgical connectome features predict IDH status in diffuse gliomas
Kesler, S. R., Harrison, R. A., Petersen, M. E., Rao, V., Dyson, H., Alfaro-Munoz, K. D., Weathers, S.-P. S., & de Groot, J. (2019) · Oncotarget · doi:10.18632/oncotarget.27301 · Cited by 22
Casares, N., Alfaro, M., Cuadrado‐Tejedor, M., Lasarte-Cía, A., Navarro, F. C., Vivas, I., Espelosin, M., Cartas‐Cejudo, P., Fernández‐Irigoyen, J., Santamaría, E., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1130044 · Cited by 21
“Activation of the immune system by infections or chronic stressful conditions, with the release of cytokines and other mediators, may have direct effects on memory, neural plasticity and neurogenesis (34, 35) having also an important role in CNS diseases.”
BackgroundChronic Helminth Infection Perturbs the Gut-Brain Axis, Promotes Neuropathology, and Alters Behavior
Giacomin, P., Kraeuter, A.-K., Albornoz, E. A., Jin, S., Bengtsson, M. M., Gordon, R., Woodruff, T. M., Urich, T., Sarnyai, Z., & Magalhães, R. J. S. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy092 · Cited by 21
“Regardless, our findings fit in with the broader paradigm shift in neurobiology and neurodegeneration where increasingly the gut microbiome (and perhaps the macrobiome, ie, worms) and interrelated factors that disturb normal homeostasis such as stress, diet, malnutrition and infections, are a major pathological trigge…”
ResultFilippov, M. A., Tatarnikova, O. G., Pozdnyakova, N. V., & Vorobyov, V. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.290878 · Cited by 21
“MS is considered as a “precondition” for the number of serious pathologies: CVDs, atherosclerosis, T2DM (Bhatti et al., 2017) and chronic renal failure (Prasad, 2014).”
BackgroundEpothilone D inhibits microglia-mediated spread of alpha-synuclein aggregates
Valdinocci, D., Grant, G. D., Dickson, T. C., & Pountney, D. L. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.04.006 · Cited by 20
“This activation is also accompanied by a morphological change in the microglial cell, from a ramified surveillant state to an amoebic phagocytic one (Jonas et al., 2012; Perry et al., 2007).”
High-Throughput Urinary Neopterin-to-Creatinine Ratio Monitoring of Systemic Inflammation
Stuart, C. M., Zotova, E., Koster, G., Varatharaj, A., Richardson, G., Cornick, F. R., Weal, M. J., Newman, T. A., Postle, A. D., & Galea, I. (2019) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2019.030007 · Cited by 20
A nomogram for predicting sepsis-associated delirium: a retrospective study in MIMIC III
Gu, Q., Yang, S., Fei, D. W. T., Lu, Y., & Yu, H. (2023) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-023-02282-5 · Cited by 20
Arosio, B., Mastronardi, L., Gussago, C., Nicolini, P., Casè, A., Ziglioli, E., & Bergamaschini, L. C. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/484021 · Cited by 20
“Yet the finding of an upregulation of A2AR in the PBMCs of subjects with a-MCI but not with AD seems to fit with the results of a previous study [31] demonstrating that in the brain cortex the increased expression of both A2AR and A1R is mainly an early event in the pathogenesis of AD [32].”
ResultRibes, S., Adam, N., Schütze, S., Regen, T., Redlich, S., Jáňová, H., Borisch, A., Hanisch, U., & Nau, R. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.07.012 · Cited by 20
“, 2004) and chronic CNS diseases with an inflammatory component including neurodegenerative diseases (Perry et al., 2007; Cunningham et al., 2009).”
BackgroundMarchalant, Y., Baranger, K., Wenk, G. L., Khrestchatisky, M., & Rivera, S. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-10 · Cited by 20
“Neuroinflammation has thus been targeted by numerous pharmacological agents [1-4].”
BackgroundSchipke, C. G., Gunter, O. L., Weinert, C., Scotton, P., Sigle, J.-P., Kallarackal, J., Kabelitz, D., Finzen, A., & Feuerhelm, A. (2019) · Neurodegenerative Disease Management · doi:10.2217/nmt-2019-0003 · Cited by 20
Accelerated brain ageing in sepsis survivors with cognitive long‐term impairment
Seidel, G., Gaser, C., Götz, T., Günther, A., & Hamzei, F. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14850 · Cited by 20
Lennol, M. P., Canelles, S., Guerra-Cantera, S., Argente, J., García‐Segura, L. M., CEBALLOS, M. L. D., Chowen, J. A., & Frago, L. M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111462 · Cited by 20
Roerink, M. E., Groen, R. J. M., Franssen, G. M., de Weem, B. L.-V., Boerman, O. C., & van der Meer, J. W. M. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-015-0149-7 · Cited by 20
“It plays an important role in immune-to-brain communication [5], and increased TNF-α is associated with rapid neurocognitive decline [6] and neuropsychiatric symptoms [7] in * Correspondence: megan.”
Stępień, A., Chalimoniuk, M., Lubina-Dąbrowska, N., Chrapusta, S. J., Galbo, H., & Langfort, J. (2013) · NeuroImmunoModulation · doi:10.1159/000348701 · Cited by 20
Park, J., Sohn, J. H., Cho, S. J., Seo, H. Y., Hwang, I.-U., Hong, Y.-C., & Kim, K.-N. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.115369 · Cited by 19
T-bet deficient mice exhibit resistance to stress-induced development of depression-like behaviors
Kim, S., Lee, H., Joung, H.-Y., Lee, G., Lee, H.-J., Shin, M., Kim, S., Shim, I., & Bae, H. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.09.008 · Cited by 19
“…the direct targets of T-bet, innate immune cells, such as macrophage and microglia cells, proposed as the source of pro-inflammatory cytokines that are secreted in response to any deviation from physiological homeostasis as a result of stress, disease, or injury (Dantzer, 2006; Perry et al., 2007).”
BackgroundJiang, X., Ganesan, P., Rengarajan, T., Choi, D., & Arulselvan, P. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.162 · Cited by 19
Gastrointestinal Changes and Alzheimer's Disease
Sohrabi, M., Sahu, B., Kaur, H., Hasler, W. A., Prakash, A. K., & Combs, C. K. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220617121255 · Cited by 19
Low-grade inflammation disrupts structural plasticity in the human brain
Szabó, C., Kelemen, O., & Kéri, S. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.06.002 · Cited by 19
Retraction to Chronic Inflammation: Accelerator of Biological Aging
Fougère, B., Boulanger, É., Nourhashémi, F., Guyonnet, S., & Cesari, M. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly284 · Cited by 19
Toll-Like Receptors in Neurodegeneration
Owens, T. (2009) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-00549-7_6 · Cited by 18
“Although other chapters in this volume will deal at greater length with pathogeninduced glial response, infectious pathogens of course may themselves provoke glial responses that have neurodegenerative impact (Kielian 2006; Perry et al. 2007).”
Backgroundvan Ton, A. M. P., Leijte, G. P., Franssen, G. M., Bruse, N., Booij, J., Doorduin, J., Rijpkema, M., Kox, M., Abdo, W. F., & Pickkers, P. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.04.004 · Cited by 18
“, 2011), ultimately resulting in exacerbation of brain pathology (Perry et al., 2007; Wendeln et al., 2018).”
Infections among individuals with multiple sclerosis, Alzheimer’s disease and Parkinson’s disease
Hu, Y., Hu, K., Song, H., Pawitan, Y., Piehl, F., & Fang, F. (2023) · Brain Communications · doi:10.1093/braincomms/fcad065 · Cited by 19
“Patients with MS, AD or PD display increased mortality,(22-24) and infections have been suggested to play a role in disease exacerbation.(18,61) However, to what extent increased risk of mortality can be attributed to infections remains less clear.”
BackgroundStrauss, A., Swann, P., Kigar, S. L., Christou, R., Yarkoni, N. S., Turner, L., Murley, A. G., Chouliaras, L., Shapiro, N. L., Ashton, N. J., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02809-w · Cited by 18
Salani, F., Ciaramella, A., Bizzoni, F., Assogna, F., Caltagirone, C., Spalletta, G., & Bossù, P. (2012) · Cytokine · doi:10.1016/j.cyto.2012.11.001 · Cited by 18
“Albeit inflammation-related brain damage is postulated to be mainly due to activation of resident microglia, neurodegenerative changes in the brain appear to be also associated with changes in the peripheral immune system [3,4].”
Anemia in men and increased Parkinson's disease risk: A population-based large scale cohort study
Rozani, V., Giladi, N., Gurevich, T., El‐Ad, B., Tsamir, J., Hemo, B., & Peretz, C. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.03.010 · Cited by 18
Maingat, F. G., Viappiani, S., Zhu, Y., Vivithanaporn, P., Ellestad, K. K., Holden, J. K., Silva, C., & Power, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902575 · Cited by 18
“In models of neurodegenerative diseases, repeated exposure to the bacterial cell wall constituent LPS accelerates the disease course (17, 18).”
BackgroundKnopp, R. C., Baumann, K. K., Wilson, M. L., Banks, W. A., & Erickson, M. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042377 · Cited by 17
“Acute inflammatory insults like LPS or other inflammatory stimuli induce behavioral responses that are thought to aid in fighting infection and limiting the spread of disease [16,17].”
BackgroundCarrera‐Juliá, S., Estrela, J. M., Zacarés, M., Navarro, M. Á., Vega‐Bello, M. J., Ortí, J. E. D. L. R., Moreno, M. L., & Drehmer, E. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1232184 · Cited by 17
“The accumulation of fat in this area has been reported to be associated with the production of proinflammatory cytokines leading to low-grade systemic inflammation (73), which has also been associated with neurodegeneration (74), decreased functional capacity (75) and cell apoptosis (76).”
BackgroundLiu, Q., Hazan, A., Grinman, E., & Angulo, J. A. (2017) · Brain Research · doi:10.1016/j.brainres.2017.01.029 · Cited by 17
Circulating inflammatory cytokine levels correlates with cognitive impairment
Marzabadi, L. R., Sadigh‐Eteghad, S., & Talebi, M. (2020) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12613 · Cited by 17
Combined Therapy of A1AR Agonists and A2AAR Antagonists in Neuroinflammation
Marucci, G., Ben, D. D., Lambertucci, C., Navia, A. M., Spinaci, A., Volpini, R., & Buccioni, M. (2021) · Molecules · doi:10.3390/molecules26041188 · Cited by 17
“Despite the reference compound ZM241385 (4-(2-[7-Amino-2-(2-furyl)[1,2,4]triazolo[2,3a][1,3,5]triazin-5-ylamino]ethyl)phenol) being the most active A2AAR antagonist and, therefore, a useful tool for characterization of responses mediated by A2AAR, it also acts as an A2BAR antagonist and blocks the cardioprotective eff…”
MethodKurakin, A. V., & Bredesen, D. E. (2020) · Aging · doi:10.18632/aging.103883 · Cited by 18
“reciprocal relationships between peripheral and central inflammation and disorders [34, 98, 99, 101].”
BackgroundSpecial issue commentary: The changing face of inflammation in the brain
Anthony, D. C., & Pitossi, F. J. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.11.005 · Cited by 17
Frank, M. G., Ball, J. B., Hopkins, S., Kelley, T., Kuzma, A. J., Thompson, R. S., Fleshner, M., & Maier, S. F. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.07.034 · Cited by 16
Zhang, H., Bi, F., Zhao, P., Cui, H., Tao, X., Zhang, J., Li, C., Cao, Y., Wang, N., & Li, H. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119464 · Cited by 17
Fitzpatrick, J.-M., Hackett, B., Costelloe, L., Hind, W. H., & Downer, E. J. (2022) · Molecules · doi:10.3390/molecules27061763 · Cited by 16
“Given the association between neurological symptoms and infection [40], we also assessed the levels of the inflammatory reactant CRP in plasma isolated from the HC and MS groups.”
BackgroundWang, Y., Cao, X., Ma, H., Tan, W., Zhang, L., Li, Z., & Gao, Y. (2016) · Brain Research · doi:10.1016/j.brainres.2016.07.045 · Cited by 16
“, 2010) and tumor necrosis factor (TNF)-α inhibit hippocampal neuronal functions, including long term potentiation (LTP) and dendritic branching, which are involved in memory formation and maintenance (Ma et al., 2015; Perry et al., 2007; Tanaka et al., 2006).”
An Iatrogenic Model of Brain Small-Vessel Disease: Post-Radiation Encephalopathy
Moretti, R., & Caruso, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186506 · Cited by 16
Ma, C., Yu, X., Li, D., Fan, Y., Tao, Q., Tang, Y., & Zheng, L. (2022) · Human & Experimental Toxicology · doi:10.1177/09603271211061497 · Cited by 16
Muzambi, R., Bhaskaran, K., Rentsch, C. T., Smeeth, L. L., Brayne, C., Garfield, V., Williams, D. M., Chaturvedi, N., & Warren‐Gash, C. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02145-z · Cited by 16
“Given that exposed participants in our study were predominantly diagnosed with more mild infections (GP-recorded infections and other LRTIs), this may explain the lack of association observed as it is hypothesised that more severe systemic infections may be more likely to trigger the release of proinflammatory cytokin…”
BackgroundKawano, T., Morikawa, A., Imori, S., Waki, S., Tamura, T., Yamanaka, D., Yamazaki, F., & Yokoyama, M. (2014) · Journal of Anesthesia · doi:10.1007/s00540-013-1786-2 · Cited by 16
“Neuroinflammation characterized by increases in production of pro-inflammatory cytokines is a common pathogenesis of cognitive dysfunction associated with a variety of neurodegenerative diseases [6, 8].”
BackgroundBecerril‐Villanueva, E., Ponce-Regalado, M. D., Pérez‐Sánchez, G., Salazar‐Juárez, A., Arreola, R., Álvarez-Sánchez, M. E., Juarez‐Ortega, M., Falfán‐Valencia, R., Hernández‐Pando, R., Morales‐Montor, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-27352-x · Cited by 16
Unraveling the Bone–Brain Communication Network
Hansda, S., & Das, H. (2025) · Biology · doi:10.3390/biology14091279 · Cited by 15
Evidence for pathophysiological commonalities between metabolic and neurodegenerative diseases
Hölscher, C. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.01.007 · Cited by 15
Morton, C. E., Forbes, H. J., Pearce, N. E., Smeeth, L. L., & Warren‐Gash, C. (2020) · Clinical Epidemiology · doi:10.2147/clep.s260243 · Cited by 15
Wu, K.-C., Lee, C.-Y., Chern, Y., & Lin, C. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.05.027 · Cited by 15
Zhang, Y., Guo, X., Gao, J., Wei, C., Zhao, S., Liu, Z., Sun, H., Wang, J., Liu, L., Li, Y., et al. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1937693 · Cited by 15
Jiang, X., Wu, Q., Zhang, C., & Wang, M. (2021) · Neurodegenerative Diseases · doi:10.1159/000519974 · Cited by 15
Gil-Martínez, A. L., Estrada, C. M., Cuenca‐Bermejo, L., Cano, J. A., Valiente, M., Martínez, C. M., Fernández‐Villalba, E., & Herrero, M. T. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-0010-z · Cited by 15
Metadata
- Authors
- Perry, V. H., Cunningham, C., & Holmes, C.
- Affiliations
- University of Southampton (GB)
- Corresponding author
- Perry, V. Hugh
- Venue
- Nature Reviews Immunology
- Published
- 2007-01-15
- Volume
- 7
- Issue
- 2
- Pages
- 161-167
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1970606114
- Cited by
- 1,027
- References
- 93
- Citations by year
- 2026: 30 · 2025: 40 · 2024: 61 · 2023: 34 · 2022: 52 · 2021: 69 · 2020: 73 · 2019: 50 · 2018: 56 · 2017: 44 · 2016: 54 · 2015: 63 · 2014: 66 · 2013: 58 · 2012: 62
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- systemic infection, inflammation, chronic neurodegeneration, neuroinflammation, Alzheimer's disease, innate immune response, disease exacerbation, multiple sclerosis relapse, upper respiratory tract infection
- MeSH terms
- Aging, Animals, Brain, Communicable Diseases, Humans, Inflammation, Microglia, Neurodegenerative Diseases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.